Image

SenseToKnow Autism Screening Device Validation Study

SenseToKnow Autism Screening Device Validation Study

Recruiting
16-36 years
All
Phase N/A

Powered by AI

Overview

This is a pivotal, prospective, double-blind, study to evaluate the sensitivity and specificity of the SenseToKnow app for the detection of autism spectrum disorder in children 16-36 months of age.

Description

This is a pivotal, prospective, double-blind, study to evaluate the sensitivity and specificity of the SenseToKnow app for the classification of autism spectrum disorder when administered by parents in a sample of patients 16-36 months of age. The trial design is a non-interventional cross-sectional study comparing the SenseToKnow app classification of autism spectrum disorder ("autism") versus non-autism with the patient's diagnostic status based on expert clinical diagnosis in a population of pediatric patients.

Eligibility

Inclusion Criteria:

  1. Duke Health pediatric patient at enrollment
  2. 16-<37 months of age at enrollment
  3. Parent/legal guardian speaks English or Spanish
  4. Parent/legal guardian understands and voluntarily provides informed consent

Exclusion Criteria:

  1. Severe motor impairment that precludes study measure completion
  2. Known genetic disorders
  3. Severe hearing or visual impairment as determined on physical examination according to parent report
  4. Acute illnesses likely to prevent successful or valid data collection
  5. Uncontrolled epilepsy or seizure disorder
  6. History or presence of a clinically significant medical disease, or a mental state that could confound the study or be detrimental to the subject as determined by the investigator
  7. Acute exacerbations of chronic illnesses likely to prevent successful or valid data collection
  8. Receiving therapies that affect vision
  9. Parent/legal guardian and/or investigator believes that the child will be unable/unwilling to sit in the parent's lap to watch the app videos
  10. Parent/legal guardian indicates that they or their child is unwilling or unable to complete the app administration, surveys, or diagnostic assessment
  11. Participants who are otherwise judged as unable to comply with the protocol by the investigator
  12. Any other factor that the investigator feels would make the study measures invalid

Study details
    Autism
    Autism Spectrum Disorder

NCT05874466

Duke University

29 May 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.